Heartbeat-Synced music therapy tested for MS pain relief
NCT ID NCT06800144
First seen Jun 27, 2026 · Last updated Aug 14, 2026 · Updated 2 times
Summary
This study tests whether listening to music or metronome sounds that match your heart rate can reduce chronic pain in people with multiple sclerosis. 45 participants will be split into three groups: one does motor imagery with a heartbeat-synced metronome, one listens to relaxing music synced to their heartbeat, and one continues usual care. All sessions are done at home via video calls over 8 weeks, and researchers will measure pain, fatigue, mood, sleep, and heart rate changes.
What this could mean
Our plain-language read of the trial. This is informational only — not medical advice or a prediction.
- Active substance
- heart rate-synchronized music therapy and motor imagery training
- What this could lead to
- If it works, this could offer a non-drug, home-based way to reduce chronic pain and improve mood, sleep, and quality of life for people with MS.
- What could go wrong
- This is a small, early-stage trial with only 45 participants, so results may not apply to everyone. The therapy is behavioral, so effects may be modest and require consistent participation.
This is an AI summary of the original study and may miss details. Read our disclaimer.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for MULTIPLE SCLEROSIS, MS are added.
By submitting, you agree to our Terms of use
Conditions
The condition(s) this trial relates to.
As listed by the trial registrant
The condition terms exactly as the trial's registrant entered them.
Contacts and locations
Locations
-
Istanbul Bilgi University
Istanbul, Turkey (Türkiye)
More trials for these conditions
Other studies related to the condition(s) this trial covers.
- Can a single injection tame stubborn multiple sclerosis?
- Could a gentle zapping of the brain ease MS fatigue and brain fog?
- Engineered immune cells take aim at autoimmune diseases
- Can an extra shot boost COVID protection in autoimmune patients?
- CAR-T therapy targets autoimmune diseases, but trial never started
- Nurse-Led video calls aim to empower MS patients